BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 27246829)

  • 21. [High expression of ICOS on CD4
    Chen X; Wang F; Cong X; Shen Q; Chen L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Dec; 36(12):1102-1108. PubMed ID: 33325362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inducible costimulator ligand regulates bleomycin-induced lung and skin fibrosis in a mouse model independently of the inducible costimulator/inducible costimulator ligand pathway.
    Tanaka C; Fujimoto M; Hamaguchi Y; Sato S; Takehara K; Hasegawa M
    Arthritis Rheum; 2010 Jun; 62(6):1723-32. PubMed ID: 20191584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and prognosis of inducible T-cell co-stimulator and its ligand in Chinese stage I-III lung adenocarcinoma patients.
    Zhan XK; Liu XK; Zhang S; Chen H
    Animal Model Exp Med; 2023 Oct; 6(5):464-473. PubMed ID: 37850501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of Inducible Co-Stimulator (ICOS) in cancer immunotherapy.
    Amatore F; Gorvel L; Olive D
    Expert Opin Biol Ther; 2020 Feb; 20(2):141-150. PubMed ID: 31738626
    [No Abstract]   [Full Text] [Related]  

  • 25. Down-regulation of ICOS ligand by interaction with ICOS functions as a regulatory mechanism for immune responses.
    Watanabe M; Takagi Y; Kotani M; Hara Y; Inamine A; Hayashi K; Ogawa S; Takeda K; Tanabe K; Abe R
    J Immunol; 2008 Apr; 180(8):5222-34. PubMed ID: 18390703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Local triggering of the ICOS coreceptor by CD11c(+) myeloid cells drives organ inflammation in lupus.
    Teichmann LL; Cullen JL; Kashgarian M; Dong C; Craft J; Shlomchik MJ
    Immunity; 2015 Mar; 42(3):552-65. PubMed ID: 25786178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-146a regulates ICOS-ICOSL signalling to limit accumulation of T follicular helper cells and germinal centres.
    Pratama A; Srivastava M; Williams NJ; Papa I; Lee SK; Dinh XT; Hutloff A; Jordan MA; Zhao JL; Casellas R; Athanasopoulos V; Vinuesa CG
    Nat Commun; 2015 Mar; 6():6436. PubMed ID: 25743066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inducible costimulator (ICOS) and ICOS ligand signaling has pivotal roles in skin wound healing via cytokine production.
    Maeda S; Fujimoto M; Matsushita T; Hamaguchi Y; Takehara K; Hasegawa M
    Am J Pathol; 2011 Nov; 179(5):2360-9. PubMed ID: 21925472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inducible T-cell co-stimulator (ICOS) and ICOS ligand are novel players in the multiple-myeloma microenvironment.
    Boggio E; Gigliotti CL; Moia R; Scotta A; Crespi I; Boggione P; De Paoli L; Deambrogi C; Garzaro M; Vidali M; Chiocchetti A; Stoppa I; Rolla R; Dianzani C; Monge C; Clemente N; Gaidano G; Dianzani U
    Br J Haematol; 2022 Mar; 196(6):1369-1380. PubMed ID: 34954822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transient blockade of the inducible costimulator pathway generates long-term tolerance to factor VIII after nonviral gene transfer into hemophilia A mice.
    Peng B; Ye P; Blazar BR; Freeman GJ; Rawlings DJ; Ochs HD; Miao CH
    Blood; 2008 Sep; 112(5):1662-72. PubMed ID: 18574023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of inducible costimulator ligand (ICOSL) expression in thyroid tissue in hyperthyroidism of Graves' disease patients.
    Wang F; Yan T; Chen L; Chen X; Liu T; Shen S; Li T; Gao L; Wang T; Sun J; Liu C; Wu H; Zhang X; Chen L
    J Clin Immunol; 2012 Dec; 32(6):1253-61. PubMed ID: 22706735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pulmonary sarcoidosis is associated with high-level inducible co-stimulator (ICOS) expression on lung regulatory T cells--possible implications for the ICOS/ICOS-ligand axis in disease course and resolution.
    Sakthivel P; Grunewald J; Eklund A; Bruder D; Wahlström J
    Clin Exp Immunol; 2016 Feb; 183(2):294-306. PubMed ID: 26415669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inducible T-Cell Costimulator Mediates Lymphocyte/Macrophage Interactions During Liver Repair.
    Ramavath NN; Gadipudi LL; Provera A; Gigliotti LC; Boggio E; Bozzola C; Albano E; Dianzani U; Sutti S
    Front Immunol; 2021; 12():786680. PubMed ID: 34925367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD4 T cells require ICOS-mediated PI3K signaling to increase T-Bet expression in the setting of anti-CTLA-4 therapy.
    Chen H; Fu T; Suh WK; Tsavachidou D; Wen S; Gao J; Ng Tang D; He Q; Sun J; Sharma P
    Cancer Immunol Res; 2014 Feb; 2(2):167-76. PubMed ID: 24778280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ICOS Promotes the Function of CD4+ Effector T Cells during Anti-OX40-Mediated Tumor Rejection.
    Metzger TC; Long H; Potluri S; Pertel T; Bailey-Bucktrout SL; Lin JC; Fu T; Sharma P; Allison JP; Feldman RM
    Cancer Res; 2016 Jul; 76(13):3684-9. PubMed ID: 27197182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel anti-human ICOSL monoclonal antibody that enhances IgG production of B cells.
    Chen J; Wang F; Cai Q; Shen S; Chen Y; Hao C; Sun J
    Monoclon Antib Immunodiagn Immunother; 2013 Apr; 32(2):125-31. PubMed ID: 23607348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-ICOSL New Antigen Receptor Domains Inhibit T Cell Proliferation and Reduce the Development of Inflammation in the Collagen-Induced Mouse Model of Rheumatoid Arthritis.
    O'Dwyer R; Kovaleva M; Zhang J; Steven J; Cummins E; Luxenberg D; Darmanin-Sheehan A; Carvalho MF; Whitters M; Saunders K; Barelle CJ
    J Immunol Res; 2018; 2018():4089459. PubMed ID: 30417018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mesothelin virus-like particle immunization controls pancreatic cancer growth through CD8+ T cell induction and reduction in the frequency of CD4+ foxp3+ ICOS- regulatory T cells.
    Zhang S; Yong LK; Li D; Cubas R; Chen C; Yao Q
    PLoS One; 2013; 8(7):e68303. PubMed ID: 23874581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of the co-stimulatory molecule inducible T-cell co-stimulator ligand (ICOSL) in the progression of experimental metabolic dysfunction-associated steatohepatitis.
    Provera A; Ramavath NN; Gadipudi LL; Gigliotti CL; Boggio E; Vecchio C; Stoppa I; Rolla R; Boldorini R; Pirisi M; Smirne C; Albano E; Dianzani U; Sutti S
    Front Immunol; 2023; 14():1290391. PubMed ID: 38077334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesenchymal stem cells regulate type 2 innate lymphoid cells via regulatory T cells through ICOS-ICOSL interaction.
    Fan X; Xu ZB; Li CL; Zhang HY; Peng YQ; He BX; Liu XQ; Chen DH; Chen D; Akdis CA; Fu QL
    Stem Cells; 2021 Jul; 39(7):975-987. PubMed ID: 33662168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.